FDA Inspection
Leo Pharma A/SLeo Pharma A/S – FDA Inspection, Jun 17, 2021
Record Details
This FDA Inspection record concerns Leo Pharma A/S, with an inspection on June 17, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Leo Pharma A/S
- Inspection Date
- June 17, 2021
- Product Type
- Drugs
View Company Profile
ID · d3d91d1e-4735-4b9d-8859-06e97d2cea0b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1176888
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Leo Pharma A/S
5| Date | Classification | Office | Project area |
|---|---|---|---|
| September 26, 2024 | VAI | Drug Quality Assurance | |
| March 21, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 15, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 15, 2011 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| June 16, 2009 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Leo Pharma A/S
- FDA Inspection 1305800 - 2024-09-26
- FDA Inspection 874505 - 2014-03-21
- FDA Inspection 745558 - 2011-09-15
- FDA Inspection 738176 - 2011-07-15
- FDA Inspection 593741 - 2009-06-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.